Table 1.
Characteristics of end-stage heart failure ACT patients used for fibrosis analysis and cardiac fibroblasts isolation
Patient | LVEF [%] | Sex | Age at TX | Cancer type | Myocardium/cardiac fibroblasts used |
---|---|---|---|---|---|
ACT-4 | 20 | Female | 65 | Mammary carcinoma | Figure 1, S. Fig. 2 |
ACT-5 | 10–15 | Male | 54 | Ewing sarcoma | Figure 1, S. Fig. 2 |
ACT-6 | 20 | Female | 53 | Wilms tumor | Figure 1, S. Fig. 2 |
ACT-7 | 20 | Male | 16 | B cell non-Hodgkin gastric lymphoma | Figure 1, S. Fig. 2 |
ACT-8 | 15 | Male | 43 | Unknown | Figure 1, S. Fig. 2 |